Marketing & Strategy

The future of the pharmaceutical and GP engagement model 

Health Industry Hub | March 18, 2020 |
[Total: 1    Average: 4/5]

As many GPs are no longer seeing pharma reps there is a growing demand for pharma companies to be forward-thinking and to look to innovative digital communication solutions, reveals a new industry white paper.   

The evolving commercial landscape provides the imperative for a new way of doing business. For pharma companies, this means recognising that GPs are time poor, and whilst choosing not to see drug reps, are raising their digital interactions with pharma. 

Half of GPs are choosing not to see drug reps. This leading to questions over what the future of pharma interactions look like, reveals a new industry white paper.

A series of surveys conducted by independent medical publisher Australian Doctor Group (ADG) shows more than half (54%) say they are too busy to see them, 53% believe they aren’t an objective source of information and 35% prefer to get their information from other places.

The decline in GP engagement is not for lack of trying on pharma’s part – with more than 40% of GP responders reporting that reps attempt to see them or speak to them in person every week.

The surveys’ findings are published for the first time in ADG’s The future of the pharmaceutical and GP engagement model white paper, which warns that the situation is set to worsen with rising GP workloads and a shift to sourcing clinical information online.

Latest Department of Health figures cited in the paper reveal Australian GPs are delivering 18% more services a year than they did a decade ago – leaving them increasingly time poor.

Meanwhile, qualitative research commissioned by ADG shows GPs are looking for real-time information and are routinely using Google searches during patient consults to make sure they have the most up-to-date information to hand.

Australian pharma companies have been slow to respond to this changing environment, the paper reveals

It highlights data from pharmaceutical consulting firm IQVIA that show, despite more GPs choosing not to see reps, investment in marketing materials for drug rep visits increased by 22% between 2015 and 2019.

However, the pharma companies and their marketing teams that are willing to embrace this new digital landscape and engage GPs in the ways they want are seeing strong positive results. 

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile


Medical News - Paramedics Association concerned over uni students being thrown in to COVID-19 frontline

Paramedics Association concerned over uni students being thrown in to COVID-19 frontline

Health Industry Hub | April 1, 2020 |

The Australian Paramedics Association NSW (APA(NSW)) has significant concerns for the safety of patients, Paramedics and university students after NSW […]


News & Trends - Medical Technology

MedTech News - Australia's private hospitals join the COVID-19 fight in new partnership

Australia’s private hospitals join the COVID-19 fight in new partnership

Health Industry Hub | April 1, 2020 |

A new partnership with the Commonwealth Government will guarantee the viability of Australia’s private hospital sector, ensuring its full capacity […]


News & Trends - Pharmaceuticals

Pharma News - Roche's adjuvant treatment PBS listed in early breast cancer

Roche’s adjuvant treatment PBS listed in early breast cancer

Health Industry Hub | April 1, 2020 |

Effective 1st April 2020, Roche’s Kadcyla is listed on the Pharmaceutical Benefits Scheme (PBS), for the adjuvant treatment of patients […]


Leadership & Management

Leadership & Management - Bill Gates's insights on COVID-19 global pandemic

Bill Gates’s insights on COVID-19 global pandemic

Health Industry Hub | April 1, 2020 |

In a recent TED Talk, philanthropist and Microsoft co-founder Bill Gates offers insights into the COVID-19 pandemic, discussing why testing […]